Author

Isabella Visuri

LONG-TERM OUTCOMES OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - THE SWEDISH PROSPECTIVE MULTICENTRE SVEAH EXTENSION STUDY
LONG-TERM OUTCOMES OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - THE SWEDISH PROSPECTIVE MULTICENTRE SVEAH EXTENSION STUDY

Isabella Visuri  et al.

LONG-TERM OUTCOMES OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - THE SWEDISH PROSPECTIVE MULTICENTRE SVEAH EXTENSION STUDY
LONG-TERM OUTCOMES OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - THE SWEDISH PROSPECTIVE MULTICENTRE SVEAH EXTENSION STUDY

THE RISK OF SERIOUS INFECTIONS BEFORE AND AFTER ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE – A RETROSPECTIVE COHORT STUDY
THE RISK OF SERIOUS INFECTIONS BEFORE AND AFTER ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE – A RETROSPECTIVE COHORT STUDY

Isabella Visuri  et al.

Item 1 - 3 / 3
1